Toxicity of Shiga Toxin 1 in the Central Nervous System of Rabbits

ABSTRACT The action of Shiga toxin (Stx) on the central nervous system was examined in rabbits. Intravenous Stx1 was 44 times more lethal than Stx2 and acted more rapidly than Stx2. However, Stx1 accumulated more slowly in the cerebrospinal fluid than did Stx2. Magnetic resonance imaging demonstrated a predominance of Stx1-dependent lesions in the spinal cord. Pretreatment of the animals with anti-Stx1 antiserum intravenously completely protected against both development of brain lesions and mortality.

[1]  T. Cheasty,et al.  Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989–91 , 1993, Epidemiology and Infection.

[2]  M. Petric,et al.  SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLS , 1983, The Lancet.

[3]  S. Ostroff,et al.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. , 1989, JAMA.

[4]  M. Kashgarian,et al.  The importance of nonrenal involvement in hemolytic-uremic syndrome. , 1980, Pediatrics.

[5]  C. Lingwood,et al.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.

[6]  R. Anderson,et al.  CLINICAL AND PATHOLOGICAL ASPECTS OF CENTRAL NERVOUS SYSTEM INVOLVEMENT IN THE HAEMOLYTIC URAEMIC SYNDROME , 1971, Australian paediatric journal.

[7]  T. Honda,et al.  Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7. , 1997, FEMS immunology and medical microbiology.

[8]  M. Mizuguchi,et al.  Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system , 1996, Acta Neuropathologica.

[9]  T. Yutsudo,et al.  Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits. , 1998, Microbial pathogenesis.

[10]  T. Yutsudo,et al.  Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. , 1987, Microbial pathogenesis.

[11]  M. Karmali,et al.  Infection by verocytotoxin-producing Escherichia coli , 1989, Clinical Microbiology Reviews.

[12]  M. Miyazaki,et al.  Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. , 1999, American journal of epidemiology.

[13]  S. Yoshida,et al.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice , 1994, Infection and immunity.

[14]  C. Lingwood,et al.  Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. , 1992, Biochemistry.

[15]  S. Yoshida,et al.  Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2 , 1996, Infection and immunity.

[16]  T. Yutsudo,et al.  Brainstem mechanisms of autonomic dysfunction in encephalopathy‐associated Shiga toxin 2 intoxication , 1999, Annals of neurology.

[17]  J. Wells,et al.  Hemorrhagic colitis associated with a rare Escherichia coli serotype. , 1983, The New England journal of medicine.

[18]  B. Rowe,et al.  Properties of strains of Escherichia coli belonging to serogroup O 157 with special reference to production of Vero cytotoxins VTl and VT2 , 1987, Epidemiology and Infection.